Stock Analysts’ new coverage for Wednesday, September 6th:
Macquarie initiated coverage on shares of AK Steel Holding Corporation (NYSE:AKS). The firm issued an outperform rating on the stock.
DA Davidson assumed coverage on shares of Amazon.com (NASDAQ:AMZN). The firm issued a buy rating on the stock.
Macquarie started coverage on shares of Commercial Metals (NYSE:CMC). Macquarie issued an underperform rating on the stock.
Barclays PLC assumed coverage on shares of Editas Medicine (NASDAQ:EDIT). The firm issued an overweight rating on the stock.
Barclays PLC initiated coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS). The firm issued an equal weight rating on the stock.
Barclays PLC began coverage on shares of Juno Therapeutics (NASDAQ:JUNO). Barclays PLC issued an overweight rating on the stock.
Barclays PLC began coverage on shares of Intellia Therapeutics (NASDAQ:NTLA). Barclays PLC issued an overweight rating on the stock.
Macquarie started coverage on shares of Nucor (NYSE:NUE). They issued a neutral rating on the stock.
Barclays PLC began coverage on shares of Spark Therapeutics (NASDAQ:ONCE). Barclays PLC issued an overweight rating on the stock.
Barclays PLC initiated coverage on shares of Puma Biotechnology (NYSE:PBYI). They issued an overweight rating on the stock.
Barclays PLC assumed coverage on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE). Barclays PLC issued an equal weight rating on the stock.
Macquarie assumed coverage on shares of Reliance Steel & Aluminum Co. (NYSE:RS). The firm issued an outperform rating on the stock.
Macquarie started coverage on shares of Schnitzer Steel Industries (NASDAQ:SCHN). The firm issued a neutral rating on the stock.
Barclays PLC assumed coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT). The firm issued an equal weight rating on the stock.
Macquarie started coverage on shares of Steel Dynamics (NASDAQ:STLD). They issued a neutral rating on the stock.
Macquarie began coverage on shares of United States Steel Corporation (NYSE:X). The firm issued an outperform rating on the stock.
